ORAGENICS INC COM USD0.001(POST REV SPLT)ORAGENICS INC COM USD0.001(POST REV SPLT)ORAGENICS INC COM USD0.001(POST REV SPLT)

ORAGENICS INC COM USD0.001(POST REV SPLT)

No trades
See on Supercharts

0A64 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

0A64 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company